At Medicinal Organic Cannabis Australia (MOCA) Pty Ltd, we are committed to providing premium-quality, pharmaceutical-grade medical cannabis to global markets. With a strong focus on regulatory compliance, efficient logistics, and strategic partnerships, we ensure a seamless and legally compliant supply chain for international buyers.
MOCA has successfully established export channels across multiple countries, working closely with government authorities, licensed pharmaceutical distributors, and healthcare providers to meet the growing demand for Australian-grown medical cannabis.
As a fully licensed importer and exporter of medical cannabis, MOCA operates under strict Australian Therapeutic Goods Administration (TGA) and Office of Drug Control (ODC) regulations. Our products comply with Good Manufacturing Practice (GMP) and Good Agricultural and Collection Practice (GACP) standards, ensuring they meet the highest quality requirements for international distribution.
MOCA currently exports to several regulated markets, including:
Germany – Europe’s largest medical cannabis market, requiring EU-GMP certification and stringent quality controls.
United Kingdom – Supplying licensed medical cannabis products under the UK Home Office regulatory framework.
New Zealand – Meeting the standards set by the Medicinal Cannabis Agency for patient access.
South America – Expanding into Brazil, Argentina, and Colombia, where medical cannabis regulations are evolving.
Asia-Pacific – Establishing partnerships in Thailand and South Korea, where medical cannabis is gaining legal recognition.
MOCA continuously monitors global regulatory changes to ensure compliance and expand into new emerging markets.
MOCA has built a robust distribution network to support international clients with seamless procurement, importation, and regulatory compliance. Our supply chain ensures:
Licensed Pharmaceutical Distributors – Partnering with government-approved distributors to facilitate legal cannabis imports.
Customs & Regulatory Support – Providing comprehensive documentation, licensing, and compliance guidance to importers.
Secure & Temperature-Controlled Shipping – Utilizing validated logistics providers to maintain product integrity and regulatory compliance.
Flexible Supply Agreements – Offering bulk purchase contracts, long-term supply agreements, and tailored distribution solutions.
Our expert team assists international buyers in navigating import regulations, customs clearance, and licensing requirements, ensuring a hassle-free process.
Germany: Supplying EU-GMP Certified Medical Cannabis
MOCA successfully partnered with a German pharmaceutical company to supply EU-GMP compliant medical cannabis for distribution to licensed pharmacies. By working closely with regulatory authorities, we ensured smooth import approval and consistent supply to meet patient demand.
United Kingdom: Expanding Patient Access to Medical Cannabis
Through a strategic alliance with a UK-based wholesaler, MOCA facilitated the importation and distribution of Australian-grown medical cannabis under the UK Home Office licensing framework. This partnership enabled increased patient access to high-quality cannabis medicines.
New Zealand: Supporting a Growing Market
As one of the leading suppliers to New Zealand’s medical cannabis program, MOCA has successfully exported and distributed THC and CBD products through government-approved channels. Our collaboration with local healthcare providers ensures that New Zealand patients receive safe and effective treatments.
MOCA continues to explore new market opportunities, adapting to changing international regulations and forging strategic partnerships with global healthcare and pharmaceutical companies. With a proven track record in compliance, quality, and supply chain efficiency, MOCA is positioned as a trusted supplier of Australian medical cannabis worldwide.